Why are Shares of Aurora Cannabis Soaring Today?

: ACB | Aurora Cannabis Inc. News, Ratings, and Charts

ACB – Aurora Cannabis (ACB) posted its third-quarter earnings report yesterday, with revenues jumping 35% from their previous quarter.

 

Aurora Cannabis (ACB) posted its third-quarter earnings report yesterday, with revenues jumping 35% from their previous quarter. As a result, shares of ACB are trading up 67% today.

Some of the highlights from the report include net revenue of $78.4 million which excludes provisions of $2.9 million. This marks an increase of 18% over the prior quarter. Consumer cannabis net revenue jumped to $41.5 million, excluding provisions and marked a 24% increase over the prior quarter.

This revenue growth was due to the launch of their Daily Special brand of cannabis in February 2020 along with an increase in Cannabis 2.0 sales. Sales of their 2.0 products started near the end of December in 2019. 

Cash cost to produce per gram of dried cannabis sold dropped to $0.85 which was down from $0.88 in Q2 2020. We like to see that ACB is maintaining a cash cost to produce per gram under $1. 

Medical cannabis net revenue came in at $31.1 million, with Canadian medical net revenue up from $25.6 million to $27.0 million due to sales growth in cannabis derivative products. ACB also recognized international medical net revenues of $4.0 million up from $1.8 million due to sales from operations in the European Union coming back online in February of 2020. ACB received a temporary halt of distribution related to an administrative permit issue in Germany that was overlooked by management. This $5,000 permit cost them close to $2 million in revenue last quarter. 

The company stated that its operational reset plan was on track to deliver the company’s commitment to positive adjusted EBITDA in Q1 of 2021. This should be possible if they continue to significantly improve their SG&A run rate and bring operating costs down further. ACB also improved their cash position to $230.2 million. ACB used $154.6 million in cash during Q3 which represents a 43% decrease over the prior quarter. 

Michael Singer, Executive Chairman and Interim CEO of ACB, said, “I am incredibly proud of the Aurora team for working through these challenging times in order to maintain uninterrupted operations at all of our production facilities and ensure we continue to meet the needs of our patients and consumers. I am also pleased that our third quarter 2020 financial results were in-line with our expectations and that we remain firmly on track with the cost-savings and Capex goals we detailed during our business transformation plan in February 2020.”

Overall we see ACB’s third-quarter results as a big step in the right direction. The market is clearly pleased with their result.  But will these gains last?  We have seen companies like OrganiGram have a positive quarter with shares jumping 40% only to sell off again as the bearishness persists. We are cautiously optimistic, and hope ACB can continue to deliver good numbers with costs coming down and stable revenue growth. 

One wild card in the next few months for ACB will be if and when they announce a new CEO. There are hopes that the new CEO will have ties to a major consumer packaged goods company. Only time will tell whether ACB has what it takes to make a full recovery but this is one step in the right direction.

(Disclosure: The author is long ACB)

Want More Great Investing Ideas?

9 “BUY THE DIP” Growth Stocks for 2020

7 “Safe-Haven” Dividend Stocks for Turbulent Times

REVISED 2020 Stock Market Outlook– Discover why there is more downside ahead and the Top 10 picks for the bear market.


ACB shares were trading at $11.12 per share on Friday afternoon, up $4.48 (+67.47%). Year-to-date, ACB has declined -57.10%, versus a -11.13% rise in the benchmark S&P 500 index during the same period.


About the Author: Aaron Missere


Aaron is an experienced investor who is also the CEO of Departures Capital. His primary focus is on the cannabis industry. He also hosts a weekly show on YouTube about marijuana stocks. Learn more about Aaron’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
ACBGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Investors: Are You Ready for November?

The S&P 500 (SPY) tumbled to end October. Is that a harbinger of more downside to come? Or will the bull market return with gusto? Investment pro Steve Reitmeister shares his time market views including a preview of his favorite stocks. Get the full story below...

3 Cybersecurity Stocks Defending Against Digital Threats

The demand for cybersecurity solutions is rising as digital threats and sophisticated cyberattacks continue to escalate. Therefore, it might be wise to keep track of cybersecurity stocks, CrowdStrike (CRWD), Palo Alto Networks (PANW), and Fortinet (FTNT), as they offer innovative solutions presenting further growth opportunities. Continue reading...

3 Oil Stocks With High Upside as Global Demand Rebounds

The outlook for oil demand growth appears promising despite economic uncertainties and worldwide supply deficit. Amid this, investing in quality oil stocks Enterprise Products Partners (EPD), Marathon Oil (MRO), and Plains All American Pipeline (PAA) could be ideal as global demand rebounds. Read more...

3 Tech Stocks Under $10 That Could Deliver Big Gains

The technology industry is booming, driven by breakthroughs and significant government investments. Thus, incorporating affordable tech stocks, Sprinklr (CXM), Sabre Corporation (SABR), and Cricut (CRCT) into your portfolio provides an accessible entry point to capitalize on the industry’s growth. Read more…

2 Concerns for Investors in October

The S&P 500 (SPY) may be touching all time highs...but recent action points to concerns on 2 fronts: inflation and earnings. Investment veteran Steve Reitmeister shares his views on these 2 timely topics along with a preview of his top stocks to buy now.

Read More Stories

More Aurora Cannabis Inc. (ACB) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All ACB News